NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $5,755,000 | +13.7% | 460,000 | 0.0% | 0.12% | +7.3% |
| Q1 2015 | $5,060,000 | -29.0% | 460,000 | 0.0% | 0.11% | -25.2% |
| Q4 2014 | $7,130,000 | +28.4% | 460,000 | 0.0% | 0.15% | +40.0% |
| Q3 2014 | $5,552,000 | -9.8% | 460,000 | -4.2% | 0.10% | -2.8% |
| Q2 2014 | $6,154,000 | +5.8% | 480,000 | 0.0% | 0.11% | +8.0% |
| Q1 2014 | $5,818,000 | +25.0% | 480,000 | +17.1% | 0.10% | +23.5% |
| Q4 2013 | $4,654,000 | +78.1% | 410,000 | +64.0% | 0.08% | +80.0% |
| Q3 2013 | $2,613,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |